GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » Other Operating Expense

Gerresheimer AG (XTER:GXI) Other Operating Expense : €24 Mil (TTM As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG Other Operating Expense?

Gerresheimer AG's Other Operating Expense for the three months ended in Feb. 2024 was €-1 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2024 was €24 Mil.

Gerresheimer AG's quarterly Other Operating Expense increased from Aug. 2023 (€-1 Mil) to Nov. 2023 (€31 Mil) but then declined from Nov. 2023 (€31 Mil) to Feb. 2024 (€-1 Mil).

Gerresheimer AG's annual Other Operating Expense increased from Nov. 2021 (€2 Mil) to Nov. 2022 (€27 Mil) but then declined from Nov. 2022 (€27 Mil) to Nov. 2023 (€26 Mil).


Gerresheimer AG Other Operating Expense Historical Data

The historical data trend for Gerresheimer AG's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Other Operating Expense Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.24 15.74 2.24 26.84 25.71

Gerresheimer AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 -5.46 -0.72 31.11 -1.10

Gerresheimer AG Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gerresheimer AG Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG (XTER:GXI) Business Description

Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Executives
Dietmar Siemssen Board of Directors
Dr. Lukas Burkhardt Board of Directors
Andrea Abt Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines